Literature DB >> 32082948

Is Transcranial Magnetic Stimulation Appropriate For Treating Adolescents with Depression?

Puneet Narang1,2,3, Katelyn Madigan1,2,3, Simrat Sarai1,2,3, Steven Lippmann1,2,3.   

Abstract

Children who are inadequately treated for depression often experience greater dysfunction. Problems can include conduct disorders, substance abuse, physical illness, and poor performance at school, work, or in psychosocial contexts. Depression can lead to a greater risk of suicide. Suicide is the third most common cause of death among adolescents, with more than 500,000 attempts made by children each year. Suicide is the third most frequent cause of death among young people ages 10 to 19 years old. Thus, proper treatment is important. Major depressive disorder in adolescents is often followed by frequent recurrences in adulthood. Imaging studies document underactivity in the left dorsolateral prefrontal cortex in subjects suffering from depression. Activation of the brain with high-frequency transcranial magnetic stimulation increases neuronal excitability and induces the growth of new connections. Though larger, randomized, controlled trials with more patients and longer follow-up are needed, the favorable side effect profile and efficacy of TMS seen so far in the literature support the use of TMS as a therapeutic intervention in children and adolescents with depression.
Copyright © 2019. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Adolescent depression; affective illness; depression; neurostimulation; transcranial magnetic stimulation

Year:  2019        PMID: 32082948      PMCID: PMC7009324     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  20 in total

1.  Transcranial magnetic stimulation in adolescent depression.

Authors:  Colleen Loo; Tara McFarquhar; Garry Walter
Journal:  Australas Psychiatry       Date:  2006-03       Impact factor: 1.369

Review 2.  A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy.

Authors:  Colleen K Loo; Philip B Mitchell
Journal:  J Affect Disord       Date:  2005-09-02       Impact factor: 4.839

3.  Long-interval cortical inhibition from the dorsolateral prefrontal cortex: a TMS-EEG study.

Authors:  Zafiris J Daskalakis; Faranak Farzan; Mera S Barr; Jerome J Maller; Robert Chen; Paul B Fitzgerald
Journal:  Neuropsychopharmacology       Date:  2008-03-05       Impact factor: 7.853

Review 4.  Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: a comprehensive review.

Authors:  F S Bersani; A Minichino; P G Enticott; L Mazzarini; N Khan; G Antonacci; R N Raccah; M Salviati; R Delle Chiaie; G Bersani; P B Fitzgerald; M Biondi
Journal:  Eur Psychiatry       Date:  2012-05-03       Impact factor: 5.361

5.  Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression.

Authors:  Roni B Cohen; Paulo S Boggio; Felipe Fregni
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

6.  The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.

Authors:  John S March; Susan Silva; Stephen Petrycki; John Curry; Karen Wells; John Fairbank; Barbara Burns; Marisa Domino; Steven McNulty; Benedetto Vitiello; Joanne Severe
Journal:  Arch Gen Psychiatry       Date:  2007-10

7.  Antidepressants and suicide risk: how did specific information in FDA safety warnings affect treatment patterns?

Authors:  Susan H Busch; Richard G Frank; Douglas L Leslie; Andrés Martin; Robert A Rosenheck; Erika G Martin; Colleen L Barry
Journal:  Psychiatr Serv       Date:  2010-01       Impact factor: 3.084

8.  NON-INVASIVE BRAIN STIMULATION IN CHILDREN: APPLICATIONS AND FUTURE DIRECTIONS.

Authors:  Thilinie Rajapakse; Adam Kirton
Journal:  Transl Neurosci       Date:  2013-06       Impact factor: 1.757

9.  Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.

Authors:  Andrea Cipriani; Xinyu Zhou; Cinzia Del Giovane; Sarah E Hetrick; Bin Qin; Craig Whittington; David Coghill; Yuqing Zhang; Philip Hazell; Stefan Leucht; Pim Cuijpers; Juncai Pu; David Cohen; Arun V Ravindran; Yiyun Liu; Kurt D Michael; Lining Yang; Lanxiang Liu; Peng Xie
Journal:  Lancet       Date:  2016-06-08       Impact factor: 79.321

10.  Developmental aspects of cortical excitability and inhibition in depressed and healthy youth: an exploratory study.

Authors:  Paul E Croarkin; Paul A Nakonezny; Charles P Lewis; Michael J Zaccariello; John E Huxsahl; Mustafa M Husain; Betsy D Kennard; Graham J Emslie; Zafiris J Daskalakis
Journal:  Front Hum Neurosci       Date:  2014-09-02       Impact factor: 3.169

View more
  1 in total

1.  HDAC1-Mediated MicroRNA-124-5p Regulates NPY to Affect Learning and Memory Abilities in Rats with Depression.

Authors:  Chunling Tang; Jian Hu
Journal:  Nanoscale Res Lett       Date:  2021-02-10       Impact factor: 4.703

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.